Loading…
Loading…
Dr. Tracey Marks addresses the common concern of whether antidepressants can stop working, confirming that this phenomenon, medically termed antidepressant tachyphylaxis or colloquially "Prozac poop-out," affects approximately 25% of individuals. She explains that this issue was first observed with MAOIs in the 1980s and later with SSRIs like Prozac, where patients initially achieve full remission but then experience a return of symptoms after several months to a year, despite consistent medication use. The core mechanism is thought to involve prolonged exposure to the antidepressant changing the sensitivity of serotonin receptors in the brain.
The podcast meticulously distinguishes true tolerance from other factors that can lead to a decline in medication effectiveness. These include changes in generic medication brands, being on an insufficient dose, the emergence of new or undiagnosed medical conditions (like low thyroid, low testosterone, chronic pain, or undiagnosed bipolar disorder), and drug-drug interactions where one medication interferes with the metabolism of the antidepressant. Dr. Marks also highlights dopamine depletion, which can manifest as emotional blunting or apathy, as a distinct experience from a full return of depressive symptoms.
Practical recommendations are provided for individuals experiencing a decline in antidepressant efficacy. These strategies include increasing the medication dose, considering a "drug holiday" (a temporary, doctor-supervised cessation to resensitize receptors), switching to an antidepressant with a different mechanism of action (e.g., from an SSRI to an SNRI or a direct receptor activator like mirtazapine or vortioxetine), or adding an augmentation medication such as aripiprazole or lithium. She emphasizes the importance of patient-doctor communication, maintaining a comprehensive medication list, and utilizing online tools like WebMD for checking drug interactions.
Broader implications discussed include the connection between chronic pain and depression, the impact of long-term opioid use on brain neuroplasticity and mood, and the potential role of diet in improving depression. Dr. Marks advises that for first or second episodes of depression, medication is typically recommended for 6 months to a year, potentially allowing individuals to taper off before tolerance becomes an issue. For anxiety, which often requires longer treatment, she reassures listeners that behavioral therapies and other medications offer alternative options, alleviating fears of running out of treatment choices.
"the short answer is yes you can it's estimated to happen in about 25% of people"
"The term was called Prozac poop out"
"The medical term for this is antidepressant tachyphylaxis which is defined as rapid development of tolerance or immunity to the effects of a drug"
"different generic brands of the same medication can have different side effects and different effectiveness"
"long-term opioid use is associated with developing or worsening depression because it alters the connections between the neurons in your brain"
"dopamine depletion and this is the experience of feeling blunted or apathetic after you've been taking the antidepressant for a while"
"some studies have suggested that this may be what's behind treatment resistance when we can't get someone to get better on a single medication or even multiple medications"
"one thought is that in the brain prolonged exposure to the antidepressant changes the serotonin receptors and how sensitive they are to medication so you lose sensitivity to the medication"
"in a 2014 paper the author Stephen targum said that the drug holiday may need to last about 3 to 4 weeks and this holiday allows the receptors to become sensitive again"
"I think the takeaway here is that a minority of people develop tolerance to antidepressants"
Related to:
Clinical Recommendations
Mechanisms Explained
Contraindications Or Warnings
Patient Actionable Advice
Prevalence Cited
Mastering Difficult Conversations: The Power of Directness and Emotional Resilience
The 'Stop Nick Shirley Act': A Threat to Investigative Journalism and Transparency
Taiwan's High-Tech Dutch Disease: Economic Specialization, Geopolitical Risks, and the Semiconductor Paradox